Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vitamin K Antagonists for Acute Deep Vein Thrombosis and Pulmonary Embolism HOKUSAÏ POST VT

NCT03757481 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03757481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vitamin K Antagonists for Acute Deep Vein Thrombosis and Pulmonary Embolism HOKUSAÏ POST VT
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
March 3, 2020
Enrollment
156 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension, deep vein thrombosis, post thrombotic syndrome